The role of epigenomics in personalized medicine

References

• Sykiotis GP, Kalliolias GD, Papavassiliou AG. Pharmacogenetic principles in the hippocratic writings. J Clin Pharmacol. 2005;45:1218–1220.
   PubMed Web of Science ®Google Scholar
• Ingelman-Sundberg M. Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and future. Trends Pharmacol Sci. 2004;25:193–200.
   PubMed Web of Science ®Google Scholar
• McCarthy JJ, McLeod HL, Ginsburg GS. Genomic medicine: a decade of successes, challenges, and opportunities. Sci Transl Med. 2013;5(189):189sr4.
   PubMed Web of Science ®Google Scholar
• Ritchie MD. The success of pharmacogenomics in moving genetic association studies from bench to bedside: study design and implementation of precision medicine in the post-GWAS era. Hum Genet. 2012;131:1615–1626.
   PubMed Web of Science ®Google Scholar
• Manolio TA, Collins FS, Cox NJ, et al. Finding the missing heritability of complex diseases. Nature. 2009;461:747–753.
   PubMed Web of Science ®Google Scholar
• Cardon LR, Harris T. Precision medicine, genomics and drug discovery. Hum Mol Genet. 2016;25:R166–R172.
   Google Scholar
• Tracy TS, Chaudhry AS, Prasad B, et al. Interindividual variability in cytochrome p450-mediated drug metabolism. Drug Metab Dispos Biol Fate Chem. 2016;44:343–351.
   PubMed Web of Science ®Google Scholar
• He Z-X, Chen X-W, Zhou Z-W, et al. Impact of physiological, pathological and environmental factors on the expression and activity of human cytochrome P450 2D6 and implications in precision medicine. Drug Metab Rev. 2015;47:470–519.
   PubMed Web of Science ®Google Scholar
• Bock C. Epigenetic biomarker development. Epigenomics. 2009;1(1):99–110.
   PubMed Web of Science ®Google Scholar
• Ladd-Acosta C. Epigenetic signatures as biomarkers of exposure. Curr Environ Health Rep. 2015;2(2):117–125.
   PubMedGoogle Scholar
• Feinberg AP. Phenotypic plasticity and the epigenetics of human disease. Nature. 2007;447(7143):433–440.
   PubMed Web of Science ®Google Scholar
• Goldberg AD, Allis CD, Bernstein E. Epigenetics: a landscape takes shape. Cell. 2007;128(4):635–638.
   PubMed Web of Science ®Google Scholar
• Conrad ND. Waddington and the origin of epigenetics. J Exp Biol. 2015;218(6):816–818.
   PubMed Web of Science ®Google Scholar
• Riggs A, Russo V, Martiensen R. Epigenetic mechanisms of gene regulation. Plainview, NY: Cold Spring Harbor Laboratory Press; 1996.
   Google Scholar
• Irizarry RA, Ladd-Acosta C, Wen B, et al. The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat Genet. 2009;41(2):178–186.
   PubMed Web of Science ®Google Scholar
• Reik W, Dean W, Walter J. Epigenetic reprogramming in mammalian development. Science. 2001;293(5532):1089–1093.
   PubMed Web of Science ®Google Scholar
• Ito S, Shen L, Dai Q, et al. Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science. 2011;333(6043):1300–1303.
   PubMed Web of Science ®Google Scholar
• Bachman M, Uribe-Lewis S, Yang X, et al. 5-Formylcytosine can be a stable DNA modification in mammals. Nat Chem Biol. 2015;11(8):555–557.
   PubMed Web of Science ®Google Scholar
• Kriaucionis S, Heintz N. The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science. 2009;324(5929):929–930.
   PubMed Web of Science ®Google Scholar
• Pastor WA, Pape UJ, Huang Y, et al. Genome-wide mapping of 5-hydroxymethylcytosine in embryonic stem cells. Nature. 2011;473:394–397.
   PubMed Web of Science ®Google Scholar
• Jenuwein T, Allis CD. Translating the histone code. Science. 2001;293(5532):1074–1080.
   PubMed Web of Science ®Google Scholar
• Luger K, Mäder AW, Richmond RK, et al. Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature. 1997;389(6648):251–260.
   PubMed Web of Science ®Google Scholar
• Bannister AJ, Kouzarides T. Regulation of chromatin by histone modifications. Cell Res. 2011;21(3):381–395.
   PubMed Web of Science ®Google Scholar
• Weber CM, Henikoff S. Histone variants: dynamic punctuation in transcription. Genes Dev. 2014;28(7):672–682.
   PubMed Web of Science ®Google Scholar
• Marques M, Laflamme L, Gervais AL, et al. Reconciling the positive and negative roles of histone H2A.Z in gene transcription. Epigenetics. 2010;5(4):267–272.
   PubMed Web of Science ®Google Scholar
• Entrevan M, Schuettengruber B, Cavalli G. Regulation of genome architecture and function by polycomb proteins. Trends Cell Biol. 2016;26(7):511–525.
   PubMed Web of Science ®Google Scholar
• Filippakopoulos P, Knapp S. Targeting bromodomains: epigenetic readers of lysine acetylation. Nat Rev Drug Discov. 2014;13(5):337–356.
   PubMed Web of Science ®Google Scholar
• Jaenisch R, Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet. 2003;33(Suppl):245–254.
   PubMed Web of Science ®Google Scholar
• Ivanov M, Barragan I, Ingelman-Sundberg M. Epigenetic mechanisms of importance for drug treatment. Trends Pharmacol Sci. 2014;35(8):384–396.
   PubMed Web of Science ®Google Scholar
• Hansen K, Helin K. Epigenetic inheritance through self-recruitment of the polycomb repressive complex 2. Epigenetics. 2009;4(3):133–138.
   PubMed Web of Science ®Google Scholar
• ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature. 2012;489(7415):57–74.
   PubMedGoogle Scholar
• Roadmap Epigenomics Consortium, Kundaje A, Meuleman W, et al. Integrative analysis of 111 reference human epigenomes. Nature. 2015;518:317–330.
   PubMed Web of Science ®Google Scholar
• Ernst J, Kheradpour P, Mikkelsen TS, et al. Mapping and analysis of chromatin state dynamics in nine human cell types. Nature. 2011;473:43–49.
   PubMed Web of Science ®Google Scholar
• Fraga MF, Ballestar E, Paz MF, et al. Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci U S A. 2005;102(30):10604–10609.
   PubMed Web of Science ®Google Scholar
• Feil R, Fraga MF. Epigenetics and the environment: emerging patterns and implications. Nat Rev Genet. 2011;13:97–109.
   Web of Science ®Google Scholar
• Rutter M. Why is the topic of the biological embedding of experiences important for translation? Dev Psychopathol. 2016;28:1245–1258.
   PubMed Web of Science ®Google Scholar
• Zhi D, Aslibekyan S, Irvin MR, et al. SNPs located at CpG sites modulate genome-epigenome interaction. Epigenetics. 2013;8:802–806.
   PubMed Web of Science ®Google Scholar
• Zhou D, Li Z, Yu D, et al. Polymorphisms involving gain or loss of CpG sites are significantly enriched in trait-associated SNPs. Oncotarget. 2015;6:39995–40004.
   PubMed Web of Science ®Google Scholar
• Cazaly E, Charlesworth J, Dickinson JL, et al. Genetic determinants of epigenetic patterns: providing insight into disease. Mol Med. 2015;21:400–409.
   PubMed Web of Science ®Google Scholar
• McClay JL, Shabalin AA, Dozmorov MG, et al. High density methylation QTL analysis in human blood via next-generation sequencing of the methylated genomic DNA fraction. Genome Biol. 2015;16:291.
   PubMed Web of Science ®Google Scholar
• García-Giménez JL. Epigenetic Biomarkers and Diagnostics. Cambridge (MA): Academic Press; 2015.
   Google Scholar
• Szyf M. Epigenetics, DNA methylation, and chromatin modifying drugs. Annu Rev Pharmacol Toxicol. 2009;49(1):243–263.
   PubMed Web of Science ®Google Scholar
• Hunter P. The second coming of epigenetic drugs: a more strategic and broader research framework could boost the development of new drugs to modify epigenetic factors and gene expression. EMBO Rep. 2015;16(3):276–279.
   PubMed Web of Science ®Google Scholar
• Suvà ML, Riggi N, Bernstein BE. Epigenetic reprogramming in cancer. Science. 2013;339:1567–1570.
   PubMed Web of Science ®Google Scholar
• Feinberg AP, Koldobskiy MA, Göndör A. Epigenetic modulators, modifiers and mediators in cancer aetiology and progression. Nat Rev Genet. 2016;17(5):284–299.
   PubMed Web of Science ®Google Scholar
• Amacher DEA. survey of established or potential epigenetic biomarkers for the accurate detection of human cancers. Biomarkers. 2015;2016(21):387–403.
   Google Scholar
• Imperiale TF, Ransohoff DF, Itzkowitz SH, et al. Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med. 2014;370(14):1287–1297.
   PubMed Web of Science ®Google Scholar
• Ladabaum U, Mannalithara A. Comparative effectiveness and cost effectiveness of a multitarget stool DNA Test to screen for colorectal neoplasia. Gastroenterology. 2016;151(3):427–439.e6.
   PubMed Web of Science ®Google Scholar
• Lee WH, Morton RA, Epstein JI, et al. Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis. Proc Natl Acad Sci U S A. 1994;91(24):11733–11737.
   PubMed Web of Science ®Google Scholar
• Partin AW, Van Neste L, Klein EA, et al. Clinical validation of an epigenetic assay to predict negative histopathological results in repeat prostate biopsies. J Urol. 2014;192(4):1081–1087.
   PubMed Web of Science ®Google Scholar
• Kessel KEMV, Neste LV, Lurkin I, et al. Evaluation of an epigenetic profile for the detection of bladder cancer in patients with hematuria. J Urol. 2016;195(3):601–607.
   PubMed Web of Science ®Google Scholar
• Schmidt B, Liebenberg V, Dietrich D, et al. SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer based on bronchial aspirates. BMC Cancer. 2010;10:600.
   PubMed Web of Science ®Google Scholar
• Dietrich D, Kneip C, Raji O, et al. Performance evaluation of the DNA methylation biomarker SHOX2 for the aid in diagnosis of lung cancer based on the analysis of bronchial aspirates. Int J Oncol. 2012;40:825–832.
   PubMed Web of Science ®Google Scholar
• Stefansson OA, Esteller M. Epigenetic modifications in breast cancer and their role in personalized medicine. Am J Pathol. 2013;183(4):1052–1063.
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011;474:609–615.
   PubMed Web of Science ®Google Scholar
• Chang S, Wang R-H, Akagi K, et al. Tumor suppressor BRCA1 epigenetically controls oncogenic microRNA-155. Nat Med. 2011;17(10):1275–1282.
   PubMed Web of Science ®Google Scholar
• Anjum S, Fourkala E-O, Zikan M, et al. A BRCA1-mutation associated DNA methylation signature in blood cells predicts sporadic breast cancer incidence and survival. Genome Med. 2014;6(6):47.
   PubMed Web of Science ®Google Scholar
• Kloten V, Becker B, Winner K, et al. Promoter hypermethylation of the tumor-suppressor genes ITIH5, DKK3, and RASSF1A as novel biomarkers for blood-based breast cancer screening. Breast Cancer Res BCR. 2013;15(1):R4.
   PubMed Web of Science ®Google Scholar
• Fackler MJ, Lopez Bujanda Z, Umbricht C, et al. Novel methylated biomarkers and a robust assay to detect circulating tumor DNA in metastatic breast cancer. Cancer Res. 2014;74(12):2160–2170.
   PubMed Web of Science ®Google Scholar
• Butkus B. Hopkins lab, cepheid developing methylated DNA panel for breast cancer Dx, monitoring. Genome Web [Internet]. 2015; Available from: https://www.genomeweb.com/molecular-diagnostics/hopkins-lab-cepheid-developing-methylated-dna-panel-breast-cancer-dx.
   Google Scholar
• Lunnon K, Smith R, Hannon E, et al. Methylomic profiling implicates cortical deregulation of ANK1 in Alzheimer’s disease. Nat Neurosci. 2014;17(9):1164–1170.
   PubMed Web of Science ®Google Scholar
• De Jager PL, Srivastava G, Lunnon K, et al. Alzheimer’s disease: early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci. Nat Neurosci. 2014;17:1156–1163.
   PubMed Web of Science ®Google Scholar
• Jowaed A, Schmitt I, Kaut O, et al. Methylation regulates alpha-synuclein expression and is decreased in parkinson’s disease patients’ brains. J Neurosci. 2010;30(18):6355–6359.
   PubMed Web of Science ®Google Scholar
• Absher DM, Li X, Waite LL, et al. Genome-wide DNA methylation analysis of systemic lupus erythematosus reveals persistent hypomethylation of interferon genes and compositional changes to CD4+ T-cell populations. Plos Genet. 2013;9(8):e1003678.
   PubMed Web of Science ®Google Scholar
• Pidsley R, Viana J, Hannon E, et al. Methylomic profiling of human brain tissue supports a neurodevelopmental origin for schizophrenia. Genome Biol. 2014;15(10):483.
   PubMed Web of Science ®Google Scholar
• Aberg KA, McClay JL, Nerella S, et al. Methylome-wide association study of schizophrenia: identifying blood biomarker signatures of environmental insults. JAMA Psychiatry. 2014;71(3):255–264.
   PubMed Web of Science ®Google Scholar
• Ladd-Acosta C, Hansen KD, Briem E, et al. Common DNA methylation alterations in multiple brain regions in autism. Mol Psychiatry. 2014;19:862–871. doi:10.1038/mp.2013.114
   Google Scholar
• Heyn H, Esteller M. DNA methylation profiling in the clinic: applications and challenges. Nat Rev Genet. 2012;13:679–692.
   PubMed Web of Science ®Google Scholar
• DeWoskin VA, Million RP. The epigenetics pipeline. Nat Rev Drug Discov. 2013;12(9):661–662.
   PubMed Web of Science ®Google Scholar
• Liang G, Gonzales FA, Jones PA, et al. Analysis of gene induction in human fibroblasts and bladder cancer cells exposed to the methylation inhibitor 5-aza-2ʹ-deoxycytidine. Cancer Res. 2002;62:961–966.
   PubMed Web of Science ®Google Scholar
• Cheishvili D, Boureau L, Szyf M. DNA demethylation and invasive cancer: implications for therapeutics. Br J Pharmacol. 2015;172(11):2705–2715.
   PubMed Web of Science ®Google Scholar
• Epigenetic PJ. Drugs for multiple sclerosis. Curr Neuropharmacol. 2016;14:3–9.
   PubMed Web of Science ®Google Scholar
• Abdel-Hameed EA, Ji H, Shata MT. HIV-Induced epigenetic alterations in host cells. Adv Exp Med Biol. 2016;879:27–38.
   PubMed Web of Science ®Google Scholar
• Sun Y, Sahbaie P, Liang D, et al. DNA methylation modulates nociceptive sensitization after incision. PLoS One. 2015;10:e0142046.
   Google Scholar
• Singh P, Konar A, Kumar A, et al. Hippocampal chromatin-modifying enzymes are pivotal for scopolamine-induced synaptic plasticity gene expression changes and memory impairment. J Neurochem. 2015;134:642–651.
   PubMed Web of Science ®Google Scholar
• Rajasethupathy P, Antonov I, Sheridan R, et al. A role for neuronal piRNAs in the epigenetic control of memory-related synaptic plasticity. Cell. 2012;149:693–707.
   PubMed Web of Science ®Google Scholar
• Lane AA, Chabner BA. Histone deacetylase inhibitors in cancer therapy. J Clin Oncol. 2009;27:5459–5468.
   PubMed Web of Science ®Google Scholar
• Falkenberg KJ, Johnstone RW. Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders. Nat Rev Drug Discov. 2014;13:673–691.
   PubMed Web of Science ®Google Scholar
• Kurita M, Holloway T, García-Bea A, et al. HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity. Nat Neurosci. 2012;15:1245–1254.
   PubMed Web of Science ®Google Scholar
• Sharma S, Taliyan R. Histone deacetylase inhibitors: future therapeutics for insulin resistance and type 2 diabetes. Pharmacol Res. 2016;113:320–326.
   PubMed Web of Science ®Google Scholar
• Daigle SR, Olhava EJ, Therkelsen CA, et al. Potent inhibition of DOT1L as treatment of MLL-fusion leukemia. Blood. 2013;122:1017–1025.
   PubMed Web of Science ®Google Scholar
• Kurmasheva RT, Sammons M, Favours E, et al. Initial testing (stage 1) of tazemetostat (EPZ-6438), a novel EZH2 inhibitor, by the pediatric preclinical testing program. Pediatr Blood Cancer. 2016;64(3)e26218.
   Google Scholar
• Chung C, Coste H, White JH, et al. Discovery and characterization of small molecule inhibitors of the BET family bromodomains. J Med Chem. 2011;54:3827–3838.
   PubMed Web of Science ®Google Scholar
• Khan SN, Khan AU. Role of histone acetylation in cell physiology and diseases: an update. Clin Chim Acta Int J Clin Chem. 2010;411:1401–1411.
   PubMed Web of Science ®Google Scholar
• Bowers EM, Yan G, Mukherjee C, et al. Virtual ligand screening of the p300/CBP histone acetyltransferase: identification of a selective small molecule inhibitor. Chem Biol. 2010;17:471–482.
   PubMedGoogle Scholar
• Gajer JM, Furdas SD, Gründer A, et al. Histone acetyltransferase inhibitors block neuroblastoma cell growth in vivo. Oncogenesis. 2015;4:e137.
   PubMed Web of Science ®Google Scholar
• Esteller M, Garcia-Foncillas J, Andion E, et al. Inactivation of the DNA-repair gene mgmt and the clinical response of gliomas to alkylating agents. N Engl J Med. 2000;343:1350–1354.
   PubMed Web of Science ®Google Scholar
• Hegi ME, Diserens A-C, Gorlia T, et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med. 2005;352:997–1003.
   PubMed Web of Science ®Google Scholar
• Fornaro L, Vivaldi C, Caparello C, et al. Pharmacoepigenetics in gastrointestinal tumors: MGMT methylation and beyond. Front Biosci Elite Ed. 2016;8:170–180.
   PubMedGoogle Scholar
• Chiam K, Centenera MM, Butler LM, et al. GSTP1 DNA methylation and expression status is indicative of 5-aza-2′-deoxycytidine efficacy in human prostate cancer cells. In: Agoulnik I, editor. PLoS ONE. 2011;6:e25634.
   Google Scholar
• Dejeux E, Rønneberg J, Solvang H, et al. DNA methylation profiling in doxorubicin treated primary locally advanced breast tumours identifies novel genes associated with survival and treatment response. Mol Cancer. 2010;9:68.
   PubMed Web of Science ®Google Scholar
• Stefansson OA, Villanueva A, Vidal A, et al. BRCA1 epigenetic inactivation predicts sensitivity to platinum-based chemotherapy in breast and ovarian cancer. Epigenetics. 2012;7:1225–1229.
   PubMed Web of Science ®Google Scholar
• Ouni M, Belot MP, Castell AL, et al. The P2 promoter of the IGF1 gene is a major epigenetic locus for GH responsiveness. Pharmacogenomics J. 2016;16:102–106.
   PubMed Web of Science ®Google Scholar
• Ivanov M, Kacevska M, Ingelman-Sundberg M. Epigenomics and interindividual differences in drug response. Clin Pharmacol Ther. 2012;92(6):727–736.
   PubMed Web of Science ®Google Scholar
• Kaut O, Schmitt I, Wüllner U. Genome-scale methylation analysis of Parkinson’s disease patients’ brains reveals DNA hypomethylation and increased mRNA expression of cytochrome P450 2E1. Neurogenetics. 2012;13:87–91.
   PubMed Web of Science ®Google Scholar
• Tokizane T, Shiina H, Igawa M, et al. Cytochrome P450 1B1 is overexpressed and regulated by hypomethylation in prostate cancer. Clin Cancer Res Off J Am Assoc Cancer Res. 2005;11:5793–5801.
   PubMed Web of Science ®Google Scholar
• Okino ST, Pookot D, Li L-C, et al. Epigenetic inactivation of the dioxin-responsive cytochrome P4501A1 gene in human prostate cancer. Cancer Res. 2006;66:7420–7428.
   PubMed Web of Science ®Google Scholar
• Gomez A, Karlgren M, Edler D, et al. Expression of CYP2W1 in colon tumors: regulation by gene methylation. Pharmacogenomics. 2007;8:1315–1325.
   PubMed Web of Science ®Google Scholar
• Schaeffeler E, Hellerbrand C, Nies AT, et al. DNA methylation is associated with downregulation of the organic cation transporter OCT1 (SLC22A1) in human hepatocellular carcinoma. Genome Med. 2011;3:82.
   PubMed Web of Science ®Google Scholar
• Liu Y, Zheng X, Yu Q, et al. Epigenetic activation of the drug transporter OCT2 sensitizes renal cell carcinoma to oxaliplatin. Sci Transl Med. 2016;8:348ra97.
   Web of Science ®Google Scholar
• Laird PW. Principles and challenges of genomewide DNA methylation analysis. Nat Rev Genet. 2010;11(3):191–203.
   PubMed Web of Science ®Google Scholar
• Krueger F, Kreck B, Franke A, et al. DNA methylome analysis using short bisulfite sequencing data. Nat Methods. 2012;9(2):145–151.
   PubMed Web of Science ®Google Scholar
• Ledford H. Epigenetics: the genome unwrapped. Nature. 2015;528(7580):S12–S13.
   Google Scholar
• Wang Y, Krishnan HR, Ghezzi A, . Drug-induced epigenetic changes produce drug tolerance. Plos Biol. 2007;5(10):e265.
   PubMed Web of Science ®Google Scholar
• Stricker SH, Köferle A, Beck S. From profiles to function in epigenomics. Nat Rev Genet. 2016;18(1):51–66.
   PubMed Web of Science ®Google Scholar
• Horvath S. DNA methylation age of human tissues and cell types. Genome Biol. 2013;14(10):R115.
   PubMed Web of Science ®Google Scholar
• Reid GK, Besterman JM, MacLeod AR. Selective inhibition of DNA methyltransferase enzymes as a novel strategy for cancer treatment. Curr Opin Mol Ther. 2002;4:130–137.
   PubMedGoogle Scholar
• Thakore PI, Black JB, Hilton IB, et al. Editing the epigenome: technologies for programmable transcription and epigenetic modulation. Nat Methods. 2016;13(2):127–137.
   PubMed Web of Science ®Google Scholar
• Lieberman-Aiden E, Van Berkum NL, Williams L, et al. Comprehensive mapping of long-range interactions reveals folding principles of the human genome. Science. 2009;326:289–293.
   PubMed Web of Science ®Google Scholar
• Rao SSP, Huntley MH, Durand NC, et al. A 3D map of the human genome at kilobase resolution reveals principles of chromatin looping. Cell. 2014;159:1665–1680.
   PubMed Web of Science ®Google Scholar
• Symmons O, Uslu VV, Tsujimura T, et al. Functional and topological characteristics of mammalian regulatory domains. Genome Res. 2014;24(3):390–400.
   PubMed Web of Science ®Google Scholar
• Fudenberg G, Imakaev M, Lu C, et al. Formation of chromosomal domains by loop extrusion. Cell Rep. 2016;15(9):2038–2049.
   PubMed Web of Science ®Google Scholar
• Sanborn AL, Rao SSP, Huang S-C, et al. Chromatin extrusion explains key features of loop and domain formation in wild-type and engineered genomes. Proc Natl Acad Sci U S A. 2015;112(47):E6456–6465.
   PubMed Web of Science ®Google Scholar
• Rickman DS, Soong TD, Moss B, et al. Oncogene-mediated alterations in chromatin conformation. Proc Natl Acad Sci U S A. 2012;109(23):9083–9088.
   PubMed Web of Science ®Google Scholar
• Valton A-L DJ. TAD disruption as oncogenic driver. Curr Opin Genet Dev. 2016;36:34–40.
   PubMed Web of Science ®Google Scholar
• Slattum P, Peron E, Ogbonna K. The pharmacology of aging. In: Fill. HM, Rockwood K, Woodhouse K, et al., Eds. Brocklehursts textb. Geriatr. Med. Gerontol. 8th ed. Philadephia PA: Saunders/Elsevier; 2016. p. Chapter 26.
   Google Scholar
• Pal S, Tyler JK. Epigenetics and aging. Sci Adv. 2016;2(5):e1600584.
   Google Scholar
• Brunet A, Berger SL. Epigenetics of aging and aging-related disease. J Gerontol A Biol Sci Med Sci. 2014;69 Suppl 1:S17–20.
   Google Scholar
• Seripa D, Panza F, Daragjati J, et al. Measuring pharmacogenetics in special groups: geriatrics. Expert Opin Drug Metab Toxicol. 2015;11:1073–1088.
   PubMed Web of Science ®Google Scholar
• Thakur BK, Zhang H, Becker A, et al. Double-stranded DNA in exosomes: a novel biomarker in cancer detection. Cell Res. 2014;24(6):766–769.
   PubMed Web of Science ®Google Scholar
• Sun W, Poschmann J, Cruz-Herrera Del Rosario R, et al. Histone acetylome-wide association study of autism spectrum disorder. Cell. 2016;167:1385–1397.e11.
   PubMed Web of Science ®Google Scholar